Published: May 06, 2022, 01:52 IST | Updated: May 06, 2022, 01:52 IST
In yet another setback to the American pharmaceutical giants, FDA has said that it's limiting the use of the Johnson & Johnson coronavirus vaccine for adults citing the risk of a rare blood clotting syndrome.